Clinical neuromythology IX. Pyramid sale in the bucket shop: DATATOP bottoms out.

Suppr

超能文献

作者信息

Landau W M

机构信息

Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110.

出版信息

Neurology. 1990 Sep;40(9):1337-9. doi: 10.1212/wnl.40.9.1337.

DOI:10.1212/wnl.40.9.1337

PMID:2118239

Abstract

摘要

相似文献

Clinical neuromythology IX. Pyramid sale in the bucket shop: DATATOP bottoms out.

Neurology. 1990 Sep;40(9):1337-9. doi: 10.1212/wnl.40.9.1337.

Drug trial for Parkinson's.帕金森病药物试验。

Science. 1987 Jun 12;236(4807):1420. doi: 10.1126/science.3109033.

DATATOP and clinical neuromythology IX.帕金森病治疗试验（DATATOP）与临床神经神话学IX

Neurology. 1991 Jun;41(6):771-7. doi: 10.1212/wnl.41.6.771.

DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group.帕金森病早期治疗：一项多中心对照临床试验。帕金森研究小组。

Arch Neurol. 1989 Oct;46(10):1052-60. doi: 10.1001/archneur.1989.00520460028009.

Adrenal-to-brain transplants continue as neurologists test two new drugs.随着神经学家测试两种新药，肾上腺到大脑的移植手术仍在继续。

JAMA. 1987 Aug 21;258(7):881-2. doi: 10.1001/jama.258.7.881.

Study design problems of DATATOP study analysis.DATATOP研究分析中的研究设计问题。

Ann Neurol. 1996 Dec;40(6):946-8. doi: 10.1002/ana.410400624.

Selegiline and Parkinson's disease. Protective and symptomatic considerations.

Drugs. 1990 May;39(5):646-51. doi: 10.2165/00003495-199039050-00002.

[A new drug for Parkinson's disease: selegiline (Eldeprine). Copenhagen, January 26-27, 1989].

Rev Prat. 1989 Oct 1;39(22):1978.

Deprenyl in Parkinson disease.司来吉兰在帕金森病中的应用

Neurology. 1981 Dec;31(12):1578. doi: 10.1212/wnl.31.12.1578.

Clinical trials of neuroprotection in Parkinson's disease: long-term selegiline and alpha-tocopherol treatment.帕金森病神经保护的临床试验：长期司来吉兰和α-生育酚治疗。

J Neural Transm Suppl. 1994;43:171-81.

引用本文的文献

Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression.帕金森进展标志物倡议：一种基于里程碑的策略，用于监测帕金森病的进展。

J Parkinsons Dis. 2023;13(6):899-916. doi: 10.3233/JPD-223433.

Measuring Surrogacy in Clinical Research: With an application to studying surrogate markers for HIV Treatment-as-Prevention.临床研究中的代孕测量：应用于研究艾滋病治疗即预防的替代指标

Stat Biosci. 2020 Dec;12(3):295-323. doi: 10.1007/s12561-019-09244-4. Epub 2019 Jun 4.

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.抗氧化剂补充剂对健康参与者及各类疾病患者死亡率的预防作用

Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD007176. doi: 10.1002/14651858.CD007176.pub2.

A latent model approach to define event onset time in the presence of measurement error.一种在存在测量误差的情况下定义事件发生时间的潜在模型方法。

Stat Interface. 2009;2(4):425-435. doi: 10.4310/sii.2009.v2.n4.a4.

Pertinacious prescription of practice paradigms: the ethical burden of coercive clinical guidelines.实践范式的顽固规定：强制性临床指南的伦理负担

Curr Neurol Neurosci Rep. 2007 Sep;7(5):355-8. doi: 10.1007/s11910-007-0054-y.

Surrogate outcomes in neurology, psychiatry, and psychopharmacology.神经病学、精神病学和精神药理学中的替代结局

Dialogues Clin Neurosci. 2006;8(3):345-52. doi: 10.31887/DCNS.2006.8.3/lstaner.

Evidence from biomarkers and surrogate endpoints.来自生物标志物和替代终点的证据。

NeuroRx. 2004 Jul;1(3):323-30. doi: 10.1602/neurorx.1.3.323.

Pharmacological treatment of Parkinson's disease.帕金森病的药物治疗

Postgrad Med J. 2000 Oct;76(900):602-10. doi: 10.1136/pmj.76.900.602.

Does selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study.司来吉兰能否延缓帕金森病的进展？对DATATOP研究的批判性重新评估。

J Neurol Neurosurg Psychiatry. 1994 Feb;57(2):217-20. doi: 10.1136/jnnp.57.2.217.

A multicenter Italian randomised study on early treatment of Parkinson disease: comparison of L-dopa, l-deprenyl and dopaminoagonists. Study design and short term results. The Italian Parkinson Study Group.

Ital J Neurol Sci. 1992 Dec;13(9):735-9. doi: 10.1007/BF02229158.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验